 BERKELEY, Calif., Jan. 03, 2023 GLOBE NEWSWIRE -- Caribou Biosciences, Inc. Nasdaq: CRBU, a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, Ph.D., Caribous president and chief executive officer, is scheduled to present a corporate update at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 11:15 am PST. 